Cone-Rod Dystrophy Clinical Trials

Find Cone-Rod Dystrophy Clinical Trials Near You

External Control, preScreening, and naTurAl hiStory of Advanced retInal Degeneration Due to Rod-cone Dystrophy (ECSTASI)

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

ECSTASI is a Natural History Study, which will be monitoring how standard of care (SoC) affect advanced rod-cone dystrophy (RCD), a type of eye disease also known as retinitis pigmentosa. No experimental, investigational or any other drug or treatment will be tested during the study. This study collects information in 3 parts: Part 1: retrospective health information from medical records (up to past 10 years), Part 2: prospective health information from in-person visits (up to 1 year), and Part 3: prospective health information from medical records (up to 1 year). Participants will decide if they wish to participate in all or only to some of these parts.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Males and females 18 years of age or older, with history of formed vision

• Clinical diagnosis of advanced retinal degeneration due to RCD

• BCVA no better than (≥) 1.0 LogMAR (≤35 Early-Treatment Diabetic Retinopathy Study \[ETDRS\] letters, or 20/200 Snellen equivalent) in at least one eye

• Documented preservation of foveal Outer Nuclear Layer (ONL) in at least one eye

Locations
Other Locations
Belgium
Ghent University Hospital
RECRUITING
Ghent
France
CHNO XV-XX Paris - CIC 1423
NOT_YET_RECRUITING
Paris
Ireland
Royal Victoria Eye And Ear Hospital
NOT_YET_RECRUITING
Dublin
Contact Information
Primary
SparingVision
info@sparingvision.com
+33143462060
Backup
Medical Director
Time Frame
Start Date: 2026-09-11
Estimated Completion Date: 2028-09
Participants
Target number of participants: 100
Treatments
Experimental: Prospective and/or retrospective data collection
This Natural History study is designed as a combination of prospective and retrospective evaluations in patients diagnosed with advanced RCD. Prospective data will be collected during in-person study visits and/or SoC routine eye examinations (not planned per protocol) as they are reported in the medical records of the participant for up to 1 year after study enrollment. Retrospective data will be collected from the medical records of the participant for up to 10 years before enrollment.
Sponsors
Leads: SparingVision

This content was sourced from clinicaltrials.gov